SOURCE: Solos Endoscopy, Inc.

March 01, 2007 08:30 ET

Solos Endoscopy, Inc. Reports Abundance of Qualified Sales Leads From the 24th Annual Miami Breast Cancer Conference

BOSTON, MA -- (MARKET WIRE) -- March 1, 2007 -- Solos Endoscopy, Inc. (PINKSHEETS: SLSY) is pleased to report that a number of successful sales leads were generated at the 24th Annual Miami Breast Cancer Conference. The Company will immediately begin following up with the doctors and medical facilities from around the world that showed interest in Solos Endoscopy's line of breast products.

The conference was designed to provide medical professionals with a comprehensive update on the latest research and medical advances in diagnosis and treatment of breast cancer. Major contributors for the event were comprised of some of the largest medical and pharmaceutical companies in the world including Bristol-Myers Squibb, AstraZeneca, Pfizer Oncology, and GlaxoSmithKline. For information about the conference, please visit

"The Miami Breast Cancer Conference was a wonderful opportunity for us to profile and demonstrate our products while fostering many new contacts in this specialized medical market," stated Dee Fletcher, Director of Breast Care Products for Solos Endoscopy, Inc.

"I was very pleased by the incredible amount of interest from a number of South American doctors and medical facilities. We have already begun to build strategic relationships that will further strengthen our position in the South American market," stated Joe Gassman, Vice President of International Sales for Solos Endoscopy, Inc.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

To automatically receive instant updates, press releases, and other information on this and other Big Apple Consulting USA companies, please visit and download your FREE copy of Big Apple ComPro.

Contact Information